Driving innovation
for Life Sciences in Europe

About EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through ground-breaking therapies and medical technology. We provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures.

Read more…

Upcoming Events

News & Updates

Job Opening: Government Affairs Manager – Digital Health

Location: Brussels, Belgium (On-site)Contract Type: Full-timeStart Date: ImmediatelyApplication Deadline: 5 December 2025 About Us EUCOPE – The European Confederation of Pharmaceutical Entrepreneurs – is growing! We represent innovative small and mid-sized pharmaceutical, biotech, and medical technology companies across the EU. To support our expanding portfolio… read more

SOUNDS OF SCIENCE PODCAST EPISODE #23 – Impact of EU legislations on the competitiveness of the life sciences sector

Sounds of Science – Episode 23 Competitiveness in Life Sciences: Report on Impact of EU Legislations In this episode of EUCOPE Sounds of Science, we launch the report titled Competitiveness of the EU Life Sciences Sector – Analysis of the impact of current and future EU legislations… read more

EUCOPE and Copenhagen Economics Publish New Report on the impact of EU Legislations on Life Sciences Competitiveness

Press Release Brussels, 17 November 2025 Today, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) published a new report titled Competitiveness of the EU Life Sciences Sector – Analysis of the impact of current and future EU legislations on the competitiveness of the EU life sciences… read more

EU Medical Countermeasures and Stockpiling Strategies: critical steps toward stronger health emergency preparedness

Brussels, 9 July 2025 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) reckons both the EU Medical Countermeasures and Stockpiling Strategies, published today, as positive steps toward improving the EU’s preparedness for future health emergencies. In an increasingly uncertain geopolitical scenario, strengthening the EU medical… read more

EU Life Sciences Strategy: a step towards a stronger, innovation-friendly ecosystem

Brussels, 2 July 2025 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) appreciates and supports the European Commission’s ambition to strengthen the EU’s healthcare ecosystem through a comprehensive EU Life Sciences Strategy. A more integrated and innovation-friendly regulatory framework is essential for the EU to… read more

SOUNDS OF SCIENCE PODCAST EPISODE #22 – Tackling Antimicrobial Resistance: EUCOPE’s Position and Industry Perspectives

Sounds of Science – Episode 22 Tackling Antimicrobial Resistance: EUCOPE’s Position and Industry Perspectives In this episode of EUCOPE Sounds of Science, the discussion centers on antimicrobial resistance (AMR), often referred to as the “silent killer” due to its escalating threat to public health and… read more

EUCOPE Member Spotlight: Q&A with Jane Cooper Senior Vice President and Region Head for Ultragenyx Europe, Middle East and Africa

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In June, we spoke with Jane Cooper Senior Vice President and Region Head for Ultragenyx Europe, Middle East and… read more

EUCOPE Response to Council Agreement on Pharma Package: Innovation must remain a priority

Brussels, 5 June 2025 – Following the negotiators in the Council having agreed their General Approach yesterday (4 June), the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) acknowledges the step forward in the legislative process and urges EU policymakers to safeguard the EU’s innovation-driven life sciences… read more

SOUNDS OF SCIENCE PODCAST EPISODE #21 – EU Biotech Act: How to ensure the biopharmaceutical sector thrives in the EU

Sounds of Science  – episode 21 – EU Biotech Act: How to ensure the biopharmaceutical sector thrives in the EU The EU Biotech Act is one of the priorities of the current Commission’s legislative mandate. Following the European Commission’s Communication on boosting biotechnology and biomanufacturing… read more

EUCOPE Member Spotlight: Q&A with Muriel O’Byrne Senior Vice President and Head of International Regulatory Affairs and the European Business Office at Regeneron

Every month, EUCOPE spotlights a member company and its great work in advancing the life sciences industry and driving innovation to serve patients better. In April, we spoke with Dr. Muriel O’Byrne, Senior Vice President and Head of International Regulatory Affairs and the European Business… read more

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership